ID: ALA1160827

Max Phase: Preclinical

Molecular Formula: C7H15NO5

Molecular Weight: 193.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NC[C@H]1OC(CO)C(O)C(O)C1O

Standard InChI:  InChI=1S/C7H15NO5/c8-1-3-5(10)7(12)6(11)4(2-9)13-3/h3-7,9-12H,1-2,8H2/t3-,4?,5?,6?,7?/m1/s1

Standard InChI Key:  CGHLMFMBMIQDFZ-GQTBHBDGSA-N

Associated Targets(Human)

Brain glycogen phosphorylase 474 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 193.20Molecular Weight (Monoisotopic): 193.0950AlogP: -3.21#Rotatable Bonds: 2
Polar Surface Area: 116.17Molecular Species: BASEHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.60CX Basic pKa: 8.80CX LogP: -3.31CX LogD: -4.71
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.32Np Likeness Score: 1.83

References

1. Pan D, Liu J, Senese C, Hopfinger AJ, Tseng Y..  (2004)  Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis.,  47  (12): [PMID:15163189] [10.1021/jm030586a]

Source